GeneDx Stock Quote WGS - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

33.53

Bid

33.30

Ask

34.00

Volume

499,397

32.72 Day's Range 35.15

1.16 52 Week Range 35.65

Market Cap

876.531M

Previous Close

32.72

Open

33.41

Last Trade

34.18

Last Trade Time

17:01:10

Financial Volume

$ 16,901,288

VWAP

33.8434

Average Volume (3m)

436,444

Shares Outstanding

26,141,701

Dividend Yield

PE Ratio

-4.98

Earnings Per Share (EPS)

-6.72

Revenue

202.57M

Net Profit

-175.77M

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and... GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It also provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. is headquartered in Stamford, Connecticut. Show more

Sector

Blank Checks

Industry

Health Services

Website

www.genedx.com

Headquarters

Wilmington, Delaware, USA

Founded

2020

GeneDx Holdings Corporation is listed in the Blank Checks sector of the NASDAQ with ticker WGS. The last closing price for GeneDx was $32.72. Over the last year, GeneDx shares have traded in a share price range of $ 1.16 to $ 35.65.

GeneDx currently has 26,141,701 shares outstanding. The market capitalization of GeneDx is $855.36 million. GeneDx has a price to earnings ratio (PE ratio) of -4.98.

GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024

STAMFORD, Conn., July 11, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will release financial...

GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients

-- New integration to streamline access for health systems and improve provider and patient journeys using Epic for electronic connections -- -- Increases commercial footprint and focus on...

GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients

STAMFORD, Conn., June 05, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the first-of-its-kind patient...

GeneDx to Participate in Upcoming Investor Conferences

STAMFORD, Conn., May 22, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will...

GeneDx Reports First Quarter 2024 Financial Results and Business Highlights

Reported first quarter 2024 revenue from continuing operations1 of $61.5M with 96% year-over-year growth of exome and genome test revenue Expanded first quarter 2024 adjusted gross margins2 from...

GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset

STAMFORD, Conn., April 23, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced a strategic partnership with...

GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024

STAMFORD, Conn., April 04, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will release financial...

GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics

STAMFORD, Conn., March 14, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced its scientific contributions...

Form 4 - Statement of changes in beneficial ownership of securities

GeneDx to Participate in 44th Annual Cowen Health Care Conference

STAMFORD, Conn., Feb. 26, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced that company...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.93	2.8527607362	32.6	35.15	31.36	357272	32.84687935	CS
4	6.71	25.0186428039	26.82	35.65	25.21	495943	30.29931398	CS
12	14.06	72.2136620442	19.47	35.65	18.8	436444	25.6642652	CS
26	30.53	1017.66666667	3	35.65	2.9801	388575	19.25261812	CS
52	26.12	352.496626181	7.41	35.65	1.16	312558	12.87161076	CS
156	22.607	206.966950471	10.923	35.65	1.16	1055508	12.75612633	CS
260	22.607	206.966950471	10.923	35.65	1.16	1055508	12.75612633	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CGTXCognition Therapeutics Inc	$ 3.49 (47.26%)	4.67M
RNAZTransCode Therapeutics Inc	$ 0.365 (23.48%)	6.79M
NAMSNewAmsterdam Pharma Company NV	$ 22.49 (19.25%)	18.82k
YIBOPlanet Image International Ltd	$ 3.40 (16.64%)	62.92k
YYGHYY Group Holding Ltd	$ 0.84 (14.60%)	743
VTVTvTv Therapeutics Inc	$ 13.0022 (-38.67%)	33.35k
CEROCERo Therapeutics Holdings Inc	$ 0.169 (-33.98%)	3.64M
TGLTreasure Global Inc	$ 1.40 (-24.32%)	54.67k
LUXHLuxUrban Hotels Inc	$ 0.1586 (-16.96%)	1.31M
GVHGlobavend Holdings Ltd	$ 0.6302 (-13.06%)	47.77k
SLNASelina Hospitality PLC	$ 0.0265 (-11.67%)	25.19M
RNAZTransCode Therapeutics Inc	$ 0.365 (23.48%)	6.79M
CGTXCognition Therapeutics Inc	$ 3.49 (47.26%)	4.67M
TLTiShares 20 plus Year Treasury Bond	$ 92.90 (-0.10%)	3.91M
CEROCERo Therapeutics Holdings Inc	$ 0.169 (-33.98%)	3.64M